Next-generation cancer vaccines and emerging immunotherapy combinations
-
Published:2024-08
Issue:8
Volume:10
Page:749-769
-
ISSN:2405-8033
-
Container-title:Trends in Cancer
-
language:en
-
Short-container-title:Trends in Cancer
Author:
Brandenburg AnneORCID,
Heine AnnkristinORCID,
Brossart Peter
Reference171 articles.
1. Cancer immunotherapy: a brief review of the history, possibilities, and challenges ahead;Oiseth;JCMT,2017
2. A guide to cancer immunotherapy: from T cell basic science to clinical practice;Waldman;Nat. Rev. Immunol.,2020
3. A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma;van der Bruggen;Science,1991
4. Towards new horizons: characterization, classification and implications of the tumour antigenic repertoire;Haen;Nat. Rev. Clin. Oncol.,2020
5. Efficacy of the MAGE-A3 cancer immunotherapeutic as adjuvant therapy in patients with resected MAGE-A3-positive non-small-cell lung cancer (MAGRIT): a randomised, double-blind, placebo-controlled, phase 3 trial;Vansteenkiste;Lancet Oncol.,2016